Document Migration

WHITE PAPERS AND CASE STUDIES

• Achieving Titer Increase Up To 4-Fold While Maintaining Product Quality

  Discover customizable solutions for antibody manufacturing, as well as services for media optimization, feeding strategy optimization, and format conversion.

• Sole-Provider FSP Model Beats Schedule, Exceeds Expectations

  See how this tight collaboration resulted in the swift acquisition of staffing at levels beyond initial expectations and propelled advancements in processes across a spectrum of workstreams.

• CDMO Accelerates Contract Manufacturing With Electronic Batch Records

  A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.

• How Early-Stage Planning Strategies Are Optimizing Drug Development

  Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

• An Introduction To MES For Cell And Gene Therapy Manufacturers

  What are manufacturing execution systems, and why are they so crucial for cell and gene therapy manufacturing?

• A Family-Owned Company Changes The Lives Of Communities In Need Using OpenFlows

  Learn about the father-son owned firm, TSA, that designed a modern sewage network to help address water quality issues. 

• Biometric Services For Large Pharmaceutical Company

  This case exemplifies the effectiveness of flexible staffing solutions in meeting the dynamic needs of the biopharmaceutical industry while maintaining control over project deliverables and timelines.

• The Burden Of MES Vendor Cloud Migration In Drug Manufacturing

  Uncover the challenges and limitations of on-premise MES vendor cloud migration, and explore the modern, cloud-based solutions that can circumvent them.

• Vial Fogging: Practical Considerations For Vial Selection

  Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.

• Top 11 Considerations For Employing A Managed Service Model

  In today’s marketplace, it is becoming more attractive for companies to hire out non-differentiating capabilities. Explore 11 key considerations when taking advantage of the high value managed service marketplace.

• Conquering Business Hurdles In Personalized Cancer Immunotherapies

  Personalized immunotherapies require an innovative commercialization model that is nimble and agile enough to respond to the individualized nature of patient populations, competition, and evolving interactions with the FDA.

• The State Of Automation, AI, And Data In Life Sciences

  Companies need to speed up their current development cycle, yet there are automation gaps across the drug development lifecycle.